CAS 1312299-39-0

Concizumab

CAS : 1312299-39-0

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, thereby blocking the

Degré de pureté : > 95%

Couleur et forme : Liquid

Masse moléculaire : 145.76 kDa

Ref: TM-T77373

Concizumab

CAS : 1312299-39-0

A neutralizing human monoclonal antibody that blocks Macrophage-stimulating 1-receptor (RON) binding to macrophage-stimulating protein (MSP).

Ref: 3D-CLA1315